Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 3046
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Mapk3
Name: mitogen activated protein kinase 3
Acc ID: CHEBI:72564
Term: temozolomide
Definition: An imidazotetrazine that is 3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine which is substituted at positions 3, 4, and 8 by methyl, oxo, and carboxamide groups, respectively. A prodrug for MTIC (5-(3-methyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide, formed by spontaneous hydrolysis of temozolomide in the body), it is used as an oral alkylating agent for the treatment of newly diagnosed malignant glioblastoma multiforme (concomitantly with radiotherapy) and malignant melanoma.
Chemical ID: MESH:C047246
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Mapk3decreases expressionISOMAPK3 (Homo sapiens)6480464CTDTemozolomide results in decreased expression of MAPK3 mRNAPMID:31758290
Mapk3increases phosphorylationISOMAPK3 (Homo sapiens)6480464CTDTemozolomide results in increased phosphorylation of MAPK3 proteinPMID:36176197
Mapk3multiple interactionsISOMAPK3 (Homo sapiens)6480464CTD[Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [Temozolomide results in increased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] inhibits the reaction [U 0126 results in decreased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [[thymoquinone co-treated with SB 203580] results in increased phosphorylation of MAPK3 protein]; [Temozolomide results in decreased susceptibility to Temozolomide] promotes the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein]; MAPK3 protein promotes the reaction [[[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone] which results in increased expression of MGMT protein]; MAPK3 protein promotes the reaction [[Temozolomide results in decreased susceptibility to Temozolomide] which affects the susceptibility to thymoquinone]PMID:36176197
Go Back to source page   Continue to Ontology report